Your browser doesn't support javascript.
loading
Impact of expanded diagnostic criteria for avoidant/restrictive food intake disorder on clinical comparisons with anorexia nervosa.
Becker, Kendra R; Keshishian, Ani C; Liebman, Rachel E; Coniglio, Kathryn A; Wang, Shirley B; Franko, Debra L; Eddy, Kamryn T; Thomas, Jennifer J.
Afiliação
  • Becker KR; Eating Disorders Clinical and Research Program, Massachusetts General Hospital.
  • Keshishian AC; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
  • Liebman RE; Eating Disorders Clinical and Research Program, Massachusetts General Hospital.
  • Coniglio KA; Eating Disorders Clinical and Research Program, Massachusetts General Hospital.
  • Wang SB; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
  • Franko DL; Department of Psychology, Rutgers University, New Brunswick, New Jersey.
  • Eddy KT; Eating Disorders Clinical and Research Program, Massachusetts General Hospital.
  • Thomas JJ; Department of Psychology, Harvard University, Boston, Massachusetts.
Int J Eat Disord ; 52(3): 230-238, 2019 03.
Article em En | MEDLINE | ID: mdl-30578644
OBJECTIVE: Avoidant/restrictive food intake disorder (ARFID) and anorexia nervosa (AN) are restrictive eating disorders. There is a proposal before the American Psychiatric Association to broaden the current DSM-5 criteria for ARFID, which currently require dietary intake that is inadequate to support energy or nutritional needs. We compared the clinical presentations of ARFID and AN in an outpatient sample to determine how a more inclusive definition of ARFID, heterogeneous for age and weight status, is distinct from AN. METHODS: As part of standard care, 138 individuals with AN or ARFID completed an online assessment battery and agreed to include their responses in research. RESULTS: Individuals with ARFID were younger, reported earlier age of onset, and had higher percent median BMI (%mBMI) than those with AN (all ps < .001). Individuals with ARFID scored lower on measures of eating pathology, depression, anxiety, and clinical impairment (all ps < .05), but did not differ from those with AN on restrictive eating (p = .52), and scored higher on food neophobia (p < .001). DISCUSSION: Allowing psychosocial impairment to be sufficient for an ARFID diagnosis resulted in a clinical picture of ARFID such that %mBMI was higher (and in the normal range) compared with AN. Differences in gender distribution, age, and age of onset remained consistent with previous research. Both groups reported similar levels of dietary restriction, although ARFID can be distinguished by relatively higher levels of food neophobia. Currently available measures of eating pathology may capture certain ARFID symptoms, but highlight the need for measures of impairment relative to ARFID.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anorexia Nervosa / Transtornos da Alimentação e da Ingestão de Alimentos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anorexia Nervosa / Transtornos da Alimentação e da Ingestão de Alimentos Idioma: En Ano de publicação: 2019 Tipo de documento: Article